Apixaban oral extended release film - TAHO Pharmaceuticals
Alternative Names: Anti-Thrombotic oral extended release film - TAHO Pharmaceuticals; Anticoagulant oral extended release film - TAHO Pharmaceuticals; TAH-3341Latest Information Update: 23 Jan 2023
At a glance
- Originator TAHO Pharmaceuticals
- Class 2 ring heterocyclic compounds; Amides; Anticoagulants; Antithrombotics; Lactams; Phenyl ethers; Pyrazoles; Pyridones; Small molecules; Vascular disorder therapies
- Mechanism of Action Factor Xa inhibitors
-
Orphan Drug Status
Orphan designation is assigned by a regulatory body to encourage companies to develop drugs for rare diseases.
- New Molecular Entity No
Highest Development Phases
- Clinical Phase Unknown Deglutition disorders
Most Recent Events
- 28 Dec 2022 Clinical trials (Proof-of-concept study) in Deglutition disorders (In the elderly) in Taiwan (PO) (TAHO Pharmaceuticals pipeline, December 2022)